Pioneering innovation in drug discovery

Redefining GPCR drug discovery by creating new classes of therapeutics

At Unco therapeutics we are focused on developing next-generation approaches to GPCR drug discovery. With extensive expertise in GPCR biology and signaling mechanisms, we design novel therapeutic strategies that go beyond traditional pharmacology. By leveraging deep insights into receptor activation and downstream signaling, we are building entirely new classes of therapeutics based on fundamentally different pharmacological principles.

Our Vision

We aim to expand the boundaries of GPCR drug discovery by enabling new therapeutic strategies that address previously intractable biology. By moving beyond conventional receptor-level pharmacology, we are working to unlock a new generation of medicines capable of treating diseases with high unmet medical need.